Heinz E Schaller

Title: Innovations and Contributions of Heinz E Schaller

Introduction

Heinz E Schaller is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and diagnostic tests for swine diseases. With a total of two patents to his name, Schaller's work has had a considerable impact on animal health.

Latest Patents

Schaller's latest patents include DNA sequences coding for Mycoplasma hypopneumoniae surface antigens. These patents detail surface antigens of swine mycoplasma, which are prepared using recombinant DNA methods. His work also encompasses a swine mycoplasma vaccine based on these antigens, methods for treating swine to prevent enzootic pneumonia using that vaccine, and diagnostic tests for detecting swine mycoplasma infections in herds. Additionally, he has developed small peptides that display the specificity of foot and mouth disease viral antigens. These peptides are useful in compositions and methods for protecting animals from FMD viral infections.

Career Highlights

Throughout his career, Schaller has worked with prominent companies in the biotechnology sector, including Biogen, N.V. and Biogen, Incorporated. His innovative approaches and research have contributed to advancements in veterinary medicine and animal health.

Collaborations

Heinz E Schaller has collaborated with notable colleagues such as Eberhard P Pfaff and Mo-Quen Klinkert. Their joint efforts have furthered research and development in the field of animal health.

Conclusion

Heinz E Schaller's contributions to biotechnology and animal health through his patents and collaborations highlight his importance as an inventor. His work continues to influence the industry and improve the health of swine populations.